Clinical trial
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of…
NCT00488345 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00488345 |
|---|---|
| Title | Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age |
| Official title | A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bacterial Infections, Intra-Abdominal Infection, Pneumonia, Bacterial, Skin Diseases, Infectious |
| Intervention type | Drug |
| Interventions | Tygacil |
| Enrollment | 59 |
| Start date | Dec 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jun 20, 2007 |
| Last update posted | Oct 24, 2012 |
| Countries | Belgium, Mexico, South Africa, Taiwan, Ukraine, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: